Skip to main content
Download PDF

Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study

BMC Infectious Diseases volume 22, Article number: 883 (2022) Cite this article

The Original Article was published on 20 October 2022

Publisher Correction: BMC Infectious Diseases (2022) 22:793 https://doi.org/10.1186/s12879-022-07774-9

In the original publication of this article [1] the footnotes of Figure 1 were accidentally omitted during the publication process. In this correction article: Fig. 1 with the footnotes is published. The original article has been updated to rectify this error. The publisher apologizes to the authors and readers for the inconvenience caused.

Fig. 1
figure 1

Flow chart of drugs prescription choices according to risk of progression of COVID-19. *Presence of at least one of the following factors: age > 65 years, BMI ≥ 30, patients chronically subjected to peritoneal dialysis or haemodialysis, uncontrolled diabetes mellitus or with chronic complications, primitive or secondary immunodeficiency (particularly concerning patients being treated with immunosuppressive drugs or less than 6 months from suspension of treatment), cardiocerebrovascular disease (including arterial hypertension with organ damage), COPD and/or other chronic respiratory diseases (lung fibrosis or patient needing O2-therapy for reasons different from SARS-CoV-2 infection), active oncological or oncohematological disease, chronic hepatopathy, hemoglobinopathies, neurodegenerative disorders. 1Patients affected by haematological malignancies/autoimmune diseases or treated with immunosuppressive drugs or transplant receivers; 2First choice in patients with eGFR > 30 ml/min and no major drug interactions; 3Useful in patients with eGFR > 30 ml/min if major drug interactions contraindicate nirmatrelvir/ritonavir or in patients with dysphagia; 4For use in patients with severe renal insufficiency and/or partially immunised (i.e., previous SARS-CoV-2 infection, vaccination course incomplete or completed more than 6 months before); 5mAbs therapy was chosen considering local epidemiology of variants of concern

Full size image

Reference

  1. Scaglione V, Rotundo S, Marascio N, De Marco C, Lionello R, Veneziano C, Berardelli L, Quirino A, Olivadese V, Serapide F, Tassone B, Morrone HL, Davoli C, La Gamba V, Bruni A, Cesana BM, Matera G, Russo A, Costanzo FS, Viglietto G, Trecarichi EM, Torti C, IDTM U. M. G. COVID-19 Group. Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study. BMC Infect Dis. 2022;22:793. https://doi.org/10.1186/s12879-022-07774-9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, “Magna Græcia” University, Viale Europa, Loc. Germaneto, 88100, Catanzaro, Italy

    Vincenzo Scaglione, Salvatore Rotundo, Rosaria Lionello, Lavinia Berardelli, Vincenzo Olivadese, Francesca Serapide, Bruno Tassone, Helen Linda Morrone, Chiara Davoli, Valentina La Gamba, Alessandro Russo, Enrico Maria Trecarichi & Carlo Torti

  2. Chair of Clinical Microbiology, Department of Health Sciences, “Magna Græcia” University, Catanzaro, Italy

    Nadia Marascio, Angela Quirino & Giovanni Matera

  3. Department of Experimental and Clinical Medicine, “Magna Græcia” University, Catanzaro, Italy

    Carmela De Marco, Claudia Veneziano & Giuseppe Viglietto

  4. Chair of Intensive Care, Department of Medical and Surgical Sciences, “Magna Græcia” University, Catanzaro, Italy

    Andrea Bruni

  5. Unit of Medical Statistics, Biometrics and Bioinformatics “Giulio A. Maccacaro”, Department of Clinical Sciences and Community Health, Faculty of Medicine and Surgery, University of Milan, Milan, Italy

    Bruno Mario Cesana

  6. Department of Experimental and Clinical Medicine, Interdepartmental Center of Services (CIS), Molecular Genomics and Pathology, “Magna Græcia” University, Catanzaro, Italy

    Francesco Saverio Costanzo

Authors
  1. Vincenzo Scaglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Rotundo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadia Marascio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carmela De Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosaria Lionello
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudia Veneziano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lavinia Berardelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angela Quirino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vincenzo Olivadese
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Francesca Serapide
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bruno Tassone
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Helen Linda Morrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Chiara Davoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Valentina La Gamba
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Andrea Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Bruno Mario Cesana
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Giovanni Matera
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Alessandro Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Francesco Saverio Costanzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Giuseppe Viglietto
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Enrico Maria Trecarichi
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Carlo Torti
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

IDTM U. M. G. COVID-19 Group

  • Enrico Maria Trecarichi
  • , Alessandro Russo
  • , Francesca Serapide
  • , Bruno Tassone
  • , Paolo Fusco
  • , Vincenzo Scaglione
  • , Chiara Davoli
  • , Rosaria Lionello
  • , Valentina La Gamba
  • , Salvatore Rotundo
  • , Helen Morrone
  • , Lavinia Berardelli
  • , Maria Teresa Tassone
  • , Vincenzo Olivadese
  • , Riccardo Serraino
  • , Chiara Costa
  • , Stefano Alcaro
  • , Caterina De Filippo
  • , Giovambattista De Sarro
  • , Arturo Pujia
  • , Aldo Quattrone
  • , Francesco Saverio Costanzo
  • , Giovanni Cuda
  • , Daniela Patrizia Foti
  • , Giuseppe Viglietto
  • , Giovanni Matera
  • , Federico Longhini
  • , Andrea Bruni
  • , Eugenio Garofalo
  • , Eugenio Biamonte
  • , Vincenzo Brescia
  • , Domenico Laganà
  • , Maria Petullà
  • , Bernardo Bertucci
  • , Angela Quirino
  • , Giorgio Settimo Barreca
  • , Aida Giancotti
  • , Luigia Gallo
  • , Angelo Lamberti
  • , Nadia Marascio
  • , Adele Emanuela De Francesco
  • , Simona Mirarchi
  •  & Carlo Torti

Corresponding author

Correspondence to Carlo Torti.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scaglione, V., Rotundo, S., Marascio, N. et al. Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study. BMC Infect Dis 22, 883 (2022). https://doi.org/10.1186/s12879-022-07871-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12879-022-07871-9

BMC Infectious Diseases

ISSN: 1471-2334

Contact us